Automated and sensitive genomic co-profiling for precision pharmacogenomics
Automated and sensitive genomic co-profiling for precision pharmacogenomics
批准号:
9303306
负责人:
Paul Clark Blainey
金额:
$13.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-24 至 2017-08-15
关键词:
AddressAffectAutoimmune ProcessBiologyBiomassCD4 Positive T LymphocytesCellsChemicalsChemistryChromatinClinicClinical MedicineComplexComputational BiologyComputer SimulationDataDevelopmentDiseaseDrug PrescriptionsEtiologyGene ExpressionGenesGenomic medicineGenomicsHistone DeacetylaseHistone Deacetylase InhibitorHumanHuman GenomeImmunityInfectionInflammatoryLibrariesLinkMapsMeasurementMentored Research Scientist Development AwardMethodsMicrofluidic MicrochipsMicrofluidicsMolecular ProfilingNeurologic ProcessNucleic AcidsPatientsPerformancePeripheral Blood Mononuclear CellPersonsPharmaceutical PreparationsPharmacogenomicsPilot ProjectsPositioning AttributePreparationProcessReportingResearch PersonnelRunningSafetySamplingSystemT-LymphocyteTechniquesTechnologyTestingTherapeuticTherapeutic EffectTimeTrainingTranslatingUrsidae FamilyValproic AcidVorinostatcomputerized toolsdesignepigenomeepigenomicsexperiencegenome sequencinggenomic profilesinhibitor/antagonistmicrobialmicrodevicenovelnovel drug classpersonalized medicinepleiotropismpolarized cellpreventresponsetranscription factortranscriptometranscriptome sequencingtubacin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Genomics methods like expression profiling and epigenomic profiling hold enormous potential benefit to parse
the effects of drugs and assess patient response to therapy in the clinic. However, the lack of advanced
sample preparation methods is a blocking issue in translating informative genomic techniques for application in
chemical biology and clinical medicine. Even advanced single-cell genomics methods require large total input
quantities and struggle to produce more than one type of genomic profile, which may not be sufficiently
informative or predictive. Powerful computational tools to integrate multiple layers of `omic information are
available and ready to accept data if available from the right samples. Thus, the need to prepare multiple
sequence library types at the same time (eg co-profiling epigenome and transcriptome) from small numbers of
primary cells in a single streamlined system is a crucial missing link in the advancement of chemical biology
and realizing the potential impact of genomic medicine. The proposed project will solve this sample
preparation challenge by establishing simultaneous epigenomic and expression co-profiling sample
preparation method from low biomass samples in an automated microfluidic device. The co-profiling sample
preparation system will constitute a single microdevice able to accept small multiple primary cell samples and
automatically produce multiple sequence library types in a single run. We will apply this capability to dissect the
pleiotropic effects of an important new drug class, histone deacetylase inhibitors (HDACi). HDACi have
(currently) unpredictable effects on gene activity, but show promise for therapeutic modulation of proliferative,
inflammatory, autoimmune, and neurological processes. To evaluate potential therapeutic effects and safety
(regarding immunity to infection) of HDACi treatment, we will co-profile HDACi-treated human primary cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
-
批准号:10729566
-
项目类别:
-
资助金额:$207.29万
-
财政年份:2023
-
负责人:Paul Clark Blainey
-
依托单位:
Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout
-
批准号:10413630
-
项目类别:
-
资助金额:$20.78万
-
财政年份:2022
-
负责人:Paul Clark Blainey
-
依托单位:
Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout
-
批准号:10620301
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2022
-
负责人:Paul Clark Blainey
-
依托单位:
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
-
批准号:10463689
-
项目类别:
-
资助金额:$168.76万
-
财政年份:2019
-
负责人:Paul Clark Blainey
-
依托单位:
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
-
批准号:10242004
-
项目类别:
-
资助金额:$158.93万
-
财政年份:2019
-
负责人:Paul Clark Blainey
-
依托单位:
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
-
批准号:10670189
-
项目类别:
-
资助金额:$158.49万
-
财政年份:2019
-
负责人:Paul Clark Blainey
-
依托单位:
High-content optical pooled genome-wide screens of SARS-CoV-2 infection
-
批准号:10166221
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2017
-
负责人:Paul Clark Blainey
-
依托单位:
Microfluidic sample preparation for genomic sequencing of clinical pathogen isolates
-
批准号:9018768
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2016
-
负责人:Paul Clark Blainey
-
依托单位:
海外基金